Home » Stocks » MASI

Masimo Corporation (MASI)

Stock Price: $254.41 USD 0.00 (0.00%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 14.01B
Revenue (ttm) 1.10B
Net Income (ttm) 222.55M
Shares Out 55.06M
EPS (ttm) 3.85
PE Ratio 66.08
Forward PE 58.48
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $254.41
Previous Close $254.41
Change ($) 0.00
Change (%) 0.00%
Day's Open 247.37
Day's Range 245.41 - 254.59
Day's Volume 170,358
52-Week Range 148.38 - 254.94

More Stats

Market Cap 14.01B
Enterprise Value 13.29B
Earnings Date (est) Jan 1, 1970
Ex-Dividend Date n/a
Shares Outstanding 55.06M
Float n/a
EPS (basic) 4.10
EPS (diluted) 3.85
FCF / Share 2.63
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.51%
FCF Yield 1.03%
Payout Ratio n/a
Shares Short 1.19M
Short Ratio 3.64
Short % of Float n/a
Beta 0.85
PE Ratio 66.08
Forward PE 58.48
P/FCF Ratio 96.97
PS Ratio 12.78
PB Ratio 9.55
Revenue 1.10B
Operating Income 252.49M
Net Income 222.55M
Free Cash Flow 144.44M
Net Cash 719.06M
Net Cash / Share 13.06
Gross Margin 57.40%
Operating Margin 23.03%
Profit Margin 20.30%
FCF Margin 13.18%
ROA 10.40%
ROE 17.64%
ROIC 41.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (9)

Buy 4
Overweight 2
Hold 2
Underweight 1
Sell 0

Analyst Consensus: Overweight

Price Target

$279.33*
(9.80% upside)
Low
270
Current: $254.41
High
290
Target: 279.33
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue938858790713630587547493439405
Revenue Growth9.27%8.61%10.85%13.14%7.41%7.2%10.95%12.36%8.28%-
Gross Profit629575522478410391359326294286
Operating Income22120818443612010479.7285.2386.52106
Net Income19619412531183.3072.5258.3862.2763.7073.53
Shares Outstanding53.4352.3051.5249.5351.3154.7156.6957.4559.6658.77
Earnings Per Share3.443.452.235.851.551.301.021.071.051.21
EPS Growth-0.29%54.71%-61.88%277.42%19.23%27.45%-4.67%1.9%-13.22%-
Dividend Per Share-------1.00-2.75
Operating Cash Flow22224056.0641911795.6155.1075.1278.9661.02
Capital Expenditures-68.38-17.13-43.68-19.71-50.39-75.06-9.43-10.52-5.06-9.56
Free Cash Flow15322212.3839966.8120.5545.6864.6173.9051.46
Cash & Equivalents68855231530613213495.4771.5513088.31
Total Debt---0.071851250.340.120.120.17
Net Cash / Debt688552315306-52.839.2395.1371.4413088.13
Assets1,3961,155905821602565439375366310
Liabilities22818618126032625711298.9986.4480.20
Book Value1,168969724560275306326273277228
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Masimo Corporation
Country United States
Employees 1,600
CEO Joe E. Kiani

Stock Information

Ticker Symbol MASI
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: MASI
IPO Date August 8, 2007

Description

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software for Masimo Root and Radical-7 monitors. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, home care providers, long term care facilities, veterinarians, and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.